Ex vivo perfusion of six-gene-edited porcine liver + Multi-drug immunosuppressive therapy for liver failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Jan 2026: Trial started, NCT07519005
  2. 9 Apr 2026: Trial registered, NCT07519005

The trials

NCT07519005: Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

State
Under way
Phase
Early Phase 1
People
1 taking part
Started
31 Jan 2026
Primary completion
3 Feb 2026
Arms
Ex Vivo Gene-Edited Porcine Liver Perfusion
Results
None posted
  1. 31 Jan 2026: Trial started
  2. 9 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.